skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Pilot studies of superfractionated radiotherapy and combination chemotherapy in limited oat cell carcinoma of the bronchus

Journal Article · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)

There are sound radiobiologic and suggestive clinical rationale for superfractionating the radiotherapeutic regimens employed for the therapy of rapidly growing malignancies. Oat cell carcinoma of the bronchus is such a tumor. The authors report their experience combining aggressive systemic combination chemotherapy with supperfractionated radiotherapy for the treatment of limited oat cell carcinoma of the bronchus. Overall, patient tolerance was satisfactory and a complete remission rate of 74% was achieved. It remains to be proven, in a prospective randomized fashion, whether this approach is superior to current conventional management.

Research Organization:
Univ. of Manitoba, Winnipeg, MB (Canada)
OSTI ID:
6268459
Journal Information:
Int. J. Radiat. Oncol., Biol. Phys.; (United States), Vol. 10:10
Country of Publication:
United States
Language:
English

Similar Records

''Total'' therapy for oat cell carcinoma of the lung
Journal Article · Sat Jan 01 00:00:00 EST 1977 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:6268459

Randomized comparison of radiotherapy with a radiotherapy-chemotherapy combination in Stage IV carcinoma of the head and neck. [/sup 60/Co]
Conference · Fri May 01 00:00:00 EDT 1981 · Cancer; (United States) · OSTI ID:6268459

Clinical trial of razoxane and radiotherapy for inoperable carcinoma of the bronchus
Conference · Sat Sep 01 00:00:00 EDT 1979 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:6268459